Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C J Porter

Showing results (31-40 of 120) with videos related to

Pageof 12
Sort By:
Transplantation|April 13, 2000
fas-fas-ligand antigen expression and its relationship to increased apoptosis in acute renal transplant rejectionC J Porter, J E Ronan, M J Cassidy
Journal of Pharmaceutical Sciences|May 1, 1996
A physicochemical basis for the effect of food on the absolute oral bioavailability of halofantrineA J Humberstone, C J Porter, W N Charman
Pediatric Cardiology|October 20, 2005
Acquired QT prolongation associated with esophagitis and acute weight loss: how to evaluate a prolonged QT intervalJ J Koch, C J Porter, M J Ackerman
Clinical Chemistry|April 1, 1978
Improved technique for developing creatine kinase isoenzyme bands by using a substrate in gelatin matrixD A Mickle, G A Washington, C J Porter
International Journal of Pharmaceutics|September 23, 2000
The formulation of Halofantrine as either non-solubilizing PEG 6000 or solubilizing lipid based solid dispersions: physical stability and absolute bioavailability assessmentS M Khoo, C J Porter, W N Charman
Journal of Pharmaceutical Sciences|July 25, 2000
Effect of short-, medium-, and long-chain fatty acid-based vehicles on the absolute oral bioavailability and intestinal lymphatic transport of halofantrine and assessment of mass balance in lymph-cannulated and non-cannulated ratsS M Caliph, W N Charman, C J Porter
The Journal of Pharmacy and Pharmacology|January 24, 2002
The impact of P-glycoprotein efflux on enterocyte residence time and enterocyte-based metabolism of verapamilB M Johnson, W N Charman, C J Porter
Journal of the Royal Army Medical Corps|March 16, 2004
Preparing for the MRCSEd (A&E)S J Leigh-Smith, C J Porter, L A Greasley
American Heart Journal|March 1, 1984
Antegrade conduction and AV node function in patients with unidirectional retrograde accessory pathwaysD Henglein, P C Gillette, A Garson, et al.
Pediatrics|February 1, 1994
Tilt-table testing and oral metoprolol therapy in young patients with unexplained syncopeA S O'Marcaigh, S G MacLellan-Tobert, C J Porter
Pageof 12

Showing results (31-40 of 120) with videos related to

Sort By:
Pageof 12
Transplantation|April 13, 2000
fas-fas-ligand antigen expression and its relationship to increased apoptosis in acute renal transplant rejectionC J Porter, J E Ronan, M J Cassidy
Journal of Pharmaceutical Sciences|May 1, 1996
A physicochemical basis for the effect of food on the absolute oral bioavailability of halofantrineA J Humberstone, C J Porter, W N Charman
Pediatric Cardiology|October 20, 2005
Acquired QT prolongation associated with esophagitis and acute weight loss: how to evaluate a prolonged QT intervalJ J Koch, C J Porter, M J Ackerman
Clinical Chemistry|April 1, 1978
Improved technique for developing creatine kinase isoenzyme bands by using a substrate in gelatin matrixD A Mickle, G A Washington, C J Porter
International Journal of Pharmaceutics|September 23, 2000
The formulation of Halofantrine as either non-solubilizing PEG 6000 or solubilizing lipid based solid dispersions: physical stability and absolute bioavailability assessmentS M Khoo, C J Porter, W N Charman
Journal of Pharmaceutical Sciences|July 25, 2000
Effect of short-, medium-, and long-chain fatty acid-based vehicles on the absolute oral bioavailability and intestinal lymphatic transport of halofantrine and assessment of mass balance in lymph-cannulated and non-cannulated ratsS M Caliph, W N Charman, C J Porter
The Journal of Pharmacy and Pharmacology|January 24, 2002
The impact of P-glycoprotein efflux on enterocyte residence time and enterocyte-based metabolism of verapamilB M Johnson, W N Charman, C J Porter
Journal of the Royal Army Medical Corps|March 16, 2004
Preparing for the MRCSEd (A&E)S J Leigh-Smith, C J Porter, L A Greasley
American Heart Journal|March 1, 1984
Antegrade conduction and AV node function in patients with unidirectional retrograde accessory pathwaysD Henglein, P C Gillette, A Garson, et al.
Pediatrics|February 1, 1994
Tilt-table testing and oral metoprolol therapy in young patients with unexplained syncopeA S O'Marcaigh, S G MacLellan-Tobert, C J Porter
Pageof 12